Answer
Not in the selected product information. These products are licensed for treatment of specific adults with multidrug-resistant HIV-1, not pre-exposure prophylaxis.
Sources for this answer
- Sunlenca 300 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
- Sunlenca 464 mg solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.